SMMT insider trading
NasdaqGM HealthcareSummit Therapeutics Inc.: insider trade history from SEC Form 4 filings.
About Summit Therapeutics Inc.
Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis for the treatment of non-small lung cancer (NSCLC) and colorectal cancer (CRC). The company has also combined ivonescimab with chemotherapy, which is in phase III clinical trial for the patients with epidermal growth factor receptor, mutated, and locally advanced or metastatic non-squamous NSCLC; first-line metastatic NSCLC; and first-line unresectable metastatic CRC. It markets its products in the United states, Canada, Europe, Japan, Latin America, Middle East, and Africa. The company was founded in 2003 and is headquartered in Miami, Florida.
Company website: www.smmttx.com
SMMT insider activity at a glance
FilingIQ tracks 73 insider transactions for SMMT in filings since Nov 10, 2020. The most recent transaction is dated Oct 8, 2026.
Across the full history, 40 open-market purchases
and 5 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
How FilingIQ classifies each line, and the seven facts it shows on every open-market purchase and sale, are documented on the methodology page.
Latest SMMT Form 4 filings
Most recent disclosures. Sign up to filter by transaction code, insider role or dollar value.
Other Healthcare tickers with recent insider activity
Most active insiders at SMMT
By number of Form 4 lines in the last 180 days.
13F funds holding SMMT
Frequently asked
- How many insider trades does FilingIQ track for SMMT?
- FilingIQ tracks 73 Form 4 insider transactions for SMMT (Summit Therapeutics Inc.), covering filings from Nov 10, 2020 onwards. 1 of those are dated within the last 90 days.
- Are SMMT insiders net buyers or net sellers?
- Across the full Form 4 history for SMMT, 40 transactions (55%) were open-market purchases and 5 (7%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does SMMT insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ links every filing to the insider's SEC CIK, marks plan trades, tax withholding, option exercises, gifts, derivatives and amendments, and shows each open-market purchase and sale with the same fixed facts. It does not rate the stock.
- What sector is SMMT in?
- Summit Therapeutics Inc. (SMMT) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $13.91B.
Methodology & sources
Every SMMT insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). How lines are classified and which facts FilingIQ adds is documented on the methodology page; the people behind it are on the team page. Not investment advice; see disclaimer.